THE LONG-TERM OUTCOME OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA AND NEGATIVE INTERIM PET FAILING ABVD MIGHT BE WORSE THAN THAT OF INTERIM PET POSITIVE PATIENTS UNDERGOING EARLY TREATMENT INTENSIFICATION WITH ESCALATED BEACOPP

被引：0
|
作者：
Zaucha, J. M. [1 ,2 ]
Malkowski, B. [3 ]
Subocz, E. [4 ]
Tajer, J. [5 ]
Kulikowski, W. [6 ]
Panebianco, M. [7 ]
Grad, J. [8 ]
Rybka, J. [9 ]
Kroll-Balcerzak, R. [10 ]
Romanowicz, A. [11 ]
Chamier-Cieminska, A. [12 ]
Kurczab, P. [13 ,14 ]
Cimino, G. [7 ]
Chauvie, S. [15 ]
Knopinska-Posluszny, W. [6 ]
Walewski, J. [5 ]
Gallamini, A. [16 ]
机构：
[1] Gdynia Oncol Ctr, Gdynia, Poland
[2] Med Univ Gdansk, Dept Oncol Propedeut, Gdansk, Poland
[3] Oncol Ctr, Dept Nucl Med, Bydgoszcz, Poland
[4] Mil Inst Med, Dept Hematol, Warsaw, Poland
[5] Maria Sklodowska Curie Mem Inst Oncol, Dept Lymphoproliferat Dis, Warsaw, Poland
[6] Warmia & Mazury Med Univ, Interior Minist Hosp, Clin Dept Hematol, Olsztyn, Poland
[7] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
[8] Reg Hosp, Hematol Unit, Opole, Poland
[9] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, Wroclaw, Poland
[10] Univ Med Sch, Dept Hematol, Poznan, Poland
[11] Cent Clin Hosp MSW, Dept Hematol, Warsaw, Poland
[12] Oncol Ctr, Dept Clin Oncol, Bydgoszcz, Poland
[13] Med Ctr Mrukmed, Outpatient Chemotherapy Unit, Rzeszow, Poland
[14] Subcarpathian Oncol Ctr, Dept Clin Oncol, Brzozow, Poland
[15] Santa Croce & Carle Hosp, Med Phys Dept, Cuneo, Italy
[16] Univ Nice, Lacassagne Canc Ctr, Res Innovat & Stat Dept, Nice, France
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P100
引用
收藏
页码：53 / 54
页数：2
相关论文
共 49 条
  • [31] MULTICENTRE CLINICAL STUDY WITH EARLY TREATMENT INTENSIFICATION IN HIGH-RISK HODGKIN LYMPHOMA (HL) PATIENTS, WITH A POSITIVE FDG-PET SCAN AFTER TWO ABVD COURSES - GITIL HD0607 STUDY
    Gallamini, A.
    Tarella, C.
    Patti, C.
    Gianni, A.
    Bolis, S.
    Trentin, L.
    Biggi, A.
    Chauvie, S.
    Mennitto, M.
    Rambaldi, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 139 - 139
  • [32] Treatment reduction in patients with advanced-stage-Hodgkin-lymphoma and negative interim PET: final results of the international randomized phase 3 trial HD18 by the German Hodgkin Study Goup
    Kreissl, S.
    Goergen, H.
    Kobe, C.
    Fuchs, M.
    Greil, R.
    Huettmann, A.
    Meissner, J.
    Feuring-Buske, M.
    Bentz, M.
    Dierlamm, J.
    Kuehnhardt, D.
    Lohri, A.
    Novak, U.
    Eichenauer, D.
    Eich, H.
    Baues, C.
    Stein, H.
    Diehl, V.
    Kuhnert, G.
    Dietlein, M.
    Engert, A.
    Borchmann, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 201 - 201
  • [33] TREATMENT REDUCTION IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA AND NEGATIVE INTERIM PET: FINAL RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 TRIAL HD18 BY THE GERMAN HODGKIN STUDY GROUP
    Borchmann, P.
    Goergen, H.
    Kobe, C.
    Fuchs, M.
    Greil, R.
    Zijlstra, J. M.
    Huettmann, A.
    Markova, J.
    Meissner, J.
    Feuring-Buske, M.
    Bentz, M.
    Dierlamm, J.
    Kuehnhardt, D.
    Lohri, A.
    Novak, U.
    Eichenauer, D.
    Eich, H.
    Baues, C.
    Stein, H.
    Diehl, V.
    Kuhnert, G.
    Dietlein, M.
    Engert, A.
    HAEMATOLOGICA, 2017, 102 : 24 - +
  • [34] Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation
    Savage, Kerry J.
    Connors, Joseph M.
    Villa, Diego R.
    Hapgood, Greg
    Gerrie, Alina S.
    Shenkier, Tamara N.
    Scott, David W.
    Gascoyne, Randy D.
    Benard, Francois
    Morris, James
    Pickles, Tom
    Parsons, Christina
    Wilson, Don
    Sehn, Laurie H.
    BLOOD, 2015, 126 (23)
  • [35] Randomized Phase III Study Comparing an Early PET Driven Treatment De Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study
    Casasnovas, Olivier
    Brice, Pauline
    Bouabdallah, Reda
    Salles, Gilles A.
    Stamatoullas, Aspasia
    Dupuis, Jehan
    Reman, Oumedaly
    Gastinne, Thomas
    Joly, Bertrand
    Bouabdallah, Krimo
    Nicolas-Virelizier, Emmanuelle
    Bologna, Serge
    Morschhauser, Franck
    Delarue, Richard
    Farhat, Hassan
    Quittet, Philippe
    Berriolo-Riedinger, Alina
    Tempescul, Adrian
    Edeline, Veronique
    Maisonneuve, Herve
    Eisenmann, Jean Claude
    Traverse-Glehen, Alexandra
    Andre, Marc
    Mounier, Nicolas
    Meignan, Michel
    Ferme, Christophe
    BLOOD, 2015, 126 (23)
  • [36] LONG-TERM FOLLOW-UP OF SWOG S0816: RESPONSE-ADAPTED THERAPY OF ADVANCED STAGE HODGKIN LYMPHOMA USING EARLY INTERIM FDG-PET IMAGING
    Friedberg, J. W.
    Li, H.
    Schoder, H.
    Straus, D.
    Moskowitz, C.
    LeBlanc, M.
    Rimsza, L. M.
    Bartlett, N. L.
    Evens, A. M.
    Mittra, E. S.
    LaCasce, A.
    Sweetenham, J.
    Barr, P. M.
    Fanale, M. A.
    Knopp, M. V.
    Noy, A.
    Hsi, E. D.
    Cook, J. R.
    Lechowicz, M. J.
    Gascoyne, R. D.
    Leonard, J.
    Kahl, B. S.
    Cheson, B. D.
    Fisher, R. I.
    Press, O. W.
    HAEMATOLOGICA, 2016, 101 : 19 - 19
  • [37] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee
    Dann, Eldad J.
    Paltiel, Ora
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 131 - 133
  • [38] Treatment Reduction in Patients with Advanced-Stage Hodgkin Lymphoma and Negative Interim FDG-PET: Final Results of the International, Randomized, Phase 3 HD18 Trial by the German Hodgkin Study Group
    Kobe, C.
    Goergen, H.
    Fuchs, M.
    Eich, H. T.
    Baues, C.
    Diehl, V.
    Kuhnert, G.
    Drzezga, A.
    Dietlein, M.
    Engert, A.
    Borchmann, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S312 - S312
  • [39] TREATMENT OF HODGKIN LYMPHOMA (HL) PATIENTS WITH DEAUVILLE SCORE 5 (DS 5) AT INTERIM PET (IPET) AFTER 2 ABVD CYCLES IN THE REAL LIFE CLINICAL PRACTICE: EXCELLENT OVERALL SURVIVAL DESPITE THE NEED OF MULTIPLE LINES OF TREATMENT.
    Guidetti, A.
    Rossi, A.
    Pavoni, C.
    Delaini, F.
    Picardi, M.
    Giordano, C.
    Trentin, L.
    Zanotti, R.
    Lissandrini, L.
    Schiavotto, C.
    Romano, A.
    Rambaldi, A.
    Viviani, S.
    Corradini, P.
    HAEMATOLOGICA, 2019, 104 : 77 - 78
  • [40] Results of the 2nd Planned Interim Analysis of the RAPID Trial (involved field radiotherapy versus no further treatment) in Patients with Clinical Stages 1A and 2A Hodgkin Lymphoma and a 'negative' FDG-PET Scan after 3 Cycles ABVD
    Radford, John
    O'Doherty, Michael
    Barrington, Sally
    Qian, Wendi
    Patrick, Philippa
    Coltart, Stewart
    Culligan, Dominic
    Wimperis, Jennie
    Bessell, Eric
    Linch, David
    Johnson, Peter
    Cunningham, David
    Lister, T. Andrew
    Hoskin, Peter
    Pettengell, Ruth
    Hancock, Bary
    Illidge, Timothy
    BLOOD, 2008, 112 (11) : 143 - 144
12345